Price
CHART BY
Historical dividends and forecast
Pfizer has so far distributed $1.29 in 2026. The next dividend will be paid on 01.12.2026
$0.802
CHART BY
Frequently asked questions
What is Pfizer's market capitalization?
The market capitalization of Pfizer is $157.03B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Pfizer's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Pfizer is 36.48. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Pfizer?
Pfizer's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.755. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Pfizer's stock?
Currently, 28 analysts cover Pfizer's stock, with a consensus target price of $28.57. Analyst ratings provide insights into the stock's expected performance.
What is Pfizer's revenue over the trailing twelve months?
Over the trailing twelve months, Pfizer reported a revenue of $63.70B.
What is the EBITDA for Pfizer?
Pfizer's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $23.51B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Pfizer?
Pfizer has a free cash flow of $10.99B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Pfizer have, and what sector and industry does it belong to?
Pfizer employs approximately 75,000 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Pfizer's shares?
The free float of Pfizer is 5.69B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $157.03B
- EPS (TTM)
- $0.755
- Free Float
- 5.69B
- P/E ratio (TTM)
- 36.48
- Revenue (TTM)
- $63.70B
- EBITDA (TTM)
- $23.51B
- Free Cashflow (TTM)
- $10.99B
Pricing
- 1D span
- $27.37$27.69
- 52W span
- $23.59$29.21
Analyst Ratings
The price target is $28.57 and the stock is covered by 28 analysts.
Buy
9
Hold
17
Sell
2
Information
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
- Employees
- 75,000
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- PFE
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet